Is REGN up or down today?
REGN is down 4.39% today, last at 930.67. This stock moved -4.39% versus the prior close.
REGN · Regeneron Pharmaceuticals
REGN (Regeneron Pharmaceuticals) is trading at 930.67, down 4.39% on the session. REGN sits at the 88% mark of its 52-week range, carries a 14-day RSI of 70, and trades above its 50-day average. Over the past month it is up 25.98%.
Leading the coverage: “Regeneron Pharmaceuticals, Inc. $REGN Stock Purchased by Compass Financial Management LLC - MarketBeat” (Google News Company, 49m ago).
REGN trades on a trailing P/E of 20.9 and is running 27.56% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
REGN is down 4.39% today, last at 930.67. This stock moved -4.39% versus the prior close.
Leading the coverage: “Regeneron Pharmaceuticals, Inc. $REGN Stock Purchased by Compass Financial Management LLC - MarketBeat” (Google News Company, 49m ago). Dominant story: Regeneron Pharmaceuticals, Inc. $REGN Stock Purchased by Compass Financial Management LLC - MarketBeat (1 source, bullish) RSI is 70 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Regeneron Pharmaceuticals, Inc. $REGN Stock Purchased by Compass Financial Management LLC - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Stock: AIA Group Ltd Decreases Holdings - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Stock: Bank Julius Baer & Co. Ltd Zurich Raises Stake - MarketBeat
Regeneron's CFO Christopher Fenimore Executes 6,000 Stock Options, Sells Shares at $950.50 Each - Kalkine Media
Regeneron Pharmaceuticals (NASDAQ:REGN) EVP Joseph Larosa Sells 4,466 Shares of Company Stock - MarketBeat